Rare diseases
Investigational molecules
Locations
Back to Czechia6 clinical trials in Policka, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on cardiovascular disease prevention and treatment are exploring innovative therapeutic approaches. Studies aim to evaluate new medications for reducing major cardiovascular events in patients with established heart conditions.
Research initiatives are particularly centered on patients with elevated lipoprotein levels and those at risk of serious cardiovascular events.
Dedicated research examining atherosclerotic cardiovascular disease treatments, with trials evaluating novel therapeutic agents for preventing heart attacks and strokes in high-risk populations.
Studies specifically target patients with established vascular disease and elevated LDL cholesterol levels.
Comprehensive research programs investigating preventive therapies for cardiovascular complications, focusing on urgent coronary interventions and long-term cardiovascular health management.
These trials aim to advance understanding of various therapeutic approaches in cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
